National Health Laboratory calls for participants to test antibody tests

The National Health Laboratory Service is looking for people to participate in a study aimed at evaluating the performance of Covid-19 rapid antibody tests.

Samples collected from the participants will be used to create banks of known positive and negative controls that scientists around the country can use to quickly and accurately test any rapid or serological tests, which check for antibodies to the novel coronavirus.

The 300 participants who will voluntarily be taking part in the study must have either once tested positive for Covid-19 or been in contact with someone who had tested positive but themselves tested negative.

With the virus constantly mutating, the study that started last year will continuously re-evaluate these tests’ performance against any newer strains that may begin to circulate.

The study’s principal investigator, pathologist Professor Elizabeth Mayne, said that the collected samples would form the backbone of the serology (antibody) validation cohort.

“The NHLS needs to test the performance of commercial assays (tests), including those that test for antibodies against SARS-CoV2 (both formal or lab-based assays and rapid tests).”

But for this study, instead of reporting on the data about the prevalence of antibodies (seroprevalence data), the study will evaluate the test performance.  

For the study, participants will be asked to share information such as age, underlying conditions such as high blood pressure and chronic lung diseases and any medications being taken. The participants will also be asked when they tested positive or negative, their travel history, and any symptoms.

The rapid tests used are from across the world, including Europe, Asia, America, and some from South African scientists.

Other countries have used these tests for similar studies, but according to Mayne, the performance data has been inconsistent and/or mixed, where they either performed well in some studies and poorly in others.

South Africa has one of the most rigorous processes worldwide. 

How long will you wait?

Vaccine Queue Calculator for South Africa

We make it make sense

If this story helped you navigate your world, subscribe to the M&G today for just R30 for the first three months

Subscribers get access to all our best journalism, subscriber-only newsletters, events and a weekly cryptic crossword.”

Marcia Zali
Marcia Zali is an award winning journalist

Related stories

WELCOME TO YOUR M&G

Already a subscriber? Sign in here

Advertising

Latest stories

Women climbing the corporate ladder need good mentorship – from...

We need to help younger women grow and to handle the difficult situations in workplaces

Serena Williams: Six memorable Grand Slam finals

Serena Williams announced on Tuesday the countdown to her retirement had begun from tennis after a career which brought her 23 Grand Slam singles titles.

Kenya’s rise as a regional geothermal power

As African countries warm to geothermal energy, the continent’s largest producer is positioning itself as a key role player in the industry

More than just luxurious sleepwear

Diagnosed with two autoimmune diseases, Carla Frankel found own business through adversity
Advertising

press releases

Loading latest Press Releases…
×